Document Details
Form
Filing Date
Jan 19, 2022
Document Date
Jan 17, 2022
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
BioXcel Therapeutics
Issuer
BioXcel Therapeutics, Inc.